» Articles » PMID: 25623282

Cell Surface Heparan Sulfate Proteoglycans Control Adhesion and Invasion of Breast Carcinoma Cells

Overview
Journal Mol Cancer
Publisher Biomed Central
Date 2015 Jan 28
PMID 25623282
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cell surface proteoglycans interact with numerous regulators of cell behavior through their glycosaminoglycan chains. The syndecan family of transmembrane proteoglycans are virtually ubiquitous cell surface receptors that are implicated in the progression of some tumors, including breast carcinoma. This may derive from their regulation of cell adhesion, but roles for specific syndecans are unresolved.

Methods: The MDA-MB231 human breast carcinoma cell line was exposed to exogenous glycosaminoglycans and changes in cell behavior monitored by western blotting, immunocytochemistry, invasion and collagen degradation assays. Selected receptors including PAR-1 and syndecans were depleted by siRNA treatments to assess cell morphology and behavior. Immunohistochemistry for syndecan-2 and its interacting partner, caveolin-2 was performed on human breast tumor tissue arrays. Two-tailed paired t-test and one-way ANOVA with Tukey's post-hoc test were used in the analysis of data.

Results: MDA-MB231 cells were shown to be highly sensitive to exogenous heparan sulfate or heparin, promoting increased spreading, focal adhesion and adherens junction formation with concomitantly reduced invasion and matrix degradation. The molecular basis for this effect was revealed to have two components. First, thrombin inhibition contributed to enhanced cell adhesion and reduced invasion. Second, a specific loss of cell surface syndecan-2 was noted. The ensuing junction formation was dependent on syndecan-4, whose role in promoting actin cytoskeletal organization is known. Syndecan-2 interacts with, and may regulate, caveolin-2. Depletion of either molecule had the same adhesion-promoting influence, along with reduced invasion, confirming a role for this complex in maintaining the invasive phenotype of mammary carcinoma cells. Finally, both syndecan-2 and caveolin-2 were upregulated in tissue arrays from breast cancer patients compared to normal mammary tissue. Moreover their expression levels were correlated in triple negative breast cancers.

Conclusion: Cell surface proteoglycans, notably syndecan-2, may be important regulators of breast carcinoma progression through regulation of cytoskeleton, cell adhesion and invasion.

Citing Articles

Therapeutic Application and Structural Features of Adeno-Associated Virus Vector.

Matsuzaka Y, Yashiro R Curr Issues Mol Biol. 2024; 46(8):8464-8498.

PMID: 39194716 PMC: 11353222. DOI: 10.3390/cimb46080499.


Syndecan-1 Levels in Females with Active Rheumatoid Arthritis.

Rodriguez-Jimenez N, Gonzalez-Ponce F, Gamez-Nava J, Ramirez-Villafana M, Saldana-Cruz A, Ponce-Guarneros J J Clin Med. 2024; 13(14).

PMID: 39064151 PMC: 11278313. DOI: 10.3390/jcm13144110.


Structural and mechanistic characterization of bifunctional heparan sulfate N-deacetylase-N-sulfotransferase 1.

Mycroft-West C, Abdelkarim S, Duyvesteyn H, Gandhi N, Skidmore M, Owens R Nat Commun. 2024; 15(1):1326.

PMID: 38351061 PMC: 10864358. DOI: 10.1038/s41467-024-45419-4.


Heparan Sulfate Modulation Affects Breast Cancer Cell Adhesion and Transmigration across In Vitro Blood-Brain Barrier.

Li Y, Shteyman D, Hachem Z, Ulay A, Fan J, Fu B Cells. 2024; 13(2).

PMID: 38275815 PMC: 10813861. DOI: 10.3390/cells13020190.


Unveiling extracellular matrix assembly: Insights and approaches through bioorthogonal chemistry.

Tavakoli S, Evans A, Oommen O, Creemers L, Nandi J, Hilborn J Mater Today Bio. 2023; 22:100768.

PMID: 37600348 PMC: 10432810. DOI: 10.1016/j.mtbio.2023.100768.


References
1.
Kamath L, Meydani A, Foss F, Kuliopulos A . Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells. Cancer Res. 2001; 61(15):5933-40. View

2.
Murakami M, Horowitz A, Tang S, Ware J, Simons M . Protein kinase C (PKC) delta regulates PKCalpha activity in a Syndecan-4-dependent manner. J Biol Chem. 2002; 277(23):20367-71. DOI: 10.1074/jbc.M202501200. View

3.
Ryu H, Lee J, Yang S, Park H, Choi S, Jung K . Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells. J Biol Chem. 2009; 284(51):35692-701. PMC: 2791000. DOI: 10.1074/jbc.M109.054254. View

4.
Choi Y, Kim H, Chung H, Hwang J, Shin J, Han I . Syndecan-2 regulates cell migration in colon cancer cells through Tiam1-mediated Rac activation. Biochem Biophys Res Commun. 2009; 391(1):921-5. DOI: 10.1016/j.bbrc.2009.11.165. View

5.
Scherer P, Lewis R, Volonte D, Engelman J, Galbiati F, Couet J . Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem. 1997; 272(46):29337-46. DOI: 10.1074/jbc.272.46.29337. View